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What constitutes an adequate surgical margin in partial mastectomy is still controversial: intra-operative specimen
radiogram is commonly used during partial mastectomy for nonpalpable lesions in order verify the adequacy of the
resection but what margin is to be considered “adequate” is still debatable.
An intraoperative specimen mammogram was performed during all consecutive conservative resections for
nonpalpable DCIS and a 15-mm radiological margin was considered “adequate”. Margins were pathologically
assessed and classified as “negative”, “close” or “positive” and the rate of margin involvement constitued the main
outcome of the study.
Among 272 conservative interventions, 80.51% had negative margins at final pathology, 3.31% had close margins
and 16.18% had positive margins.
An intraoperative “adequate” margin of 15 mm as defined on intraoperative specimen mammogram granted a
high rate of histologically negative margin at primary surgery; this finding was paralleled by confirmation of the
treatment as conservative in 95% of cases.Introduction
Partial mastectomy is considered to be optimally performed
by achieving adequate surgical margins during the initial
operation while maintaining maximum cosmetic appear-
ance of the breast (McCahill et al. 2012). When treating
DCIS, such a perspective stems from either oncological
concerns and quality assessment measures: from the onco-
logical viewpoint, margins involvement by DCIS after
breast-conservative treatment has been demonstrated to be
associated with an approximate twofold overall increased
risk of invasive ipsilateral breast tumor recurrence (Fisher
et al. 1999; Wapnir et al. 2011) and, as far as quality out-
comes are concerned, re-excisions increase the risk of post-
operative infections, negatively impact cosmesis and
increase medical costs due to a longer hospital stay (Thill
et al. 2011); besides, re-excision may significantly alter a* Correspondence: federicobuggi@hotmail.com
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in any medium, provided the original work is ppatient’s initial choice of treatment due to the impossibility
of performing conservative operations as a secondary sur-
gery in a high percentage of cases (10-36%) (McCahill
et al. 2012).
Yet, what constitutes an adequate surgical margin in
partial mastectomy is still an open question and, in facts,
failure to achieve appropriate margins at the initial oper-
ation may lead to re-excision in up to 30-60% of cases
(McCahill et al. 2012).
In patients undergoing localization lumpectomy for non-
palpable breast cancer, it was suggested that a reliable peri-
operative predictor of margin involvement could guide the
extent of excision and therefore reduce the drawbacks that
come along with re-operation (Reedijk et al. 2012).
Intra-operative specimen radiogram is widely used in
partial mastectomy for non-palpable lesions in order to
verify the adequacy of the resection but, to the best of
our knowledge, reports on the actual assessment methodn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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equacy of excision remains elusive (Chagpar et al. 2003).
We report the criteria that were adopted for defining
margins adequacy on intra-operative specimen mammo-
gram in a series of conservative treatments for non-
palpable DCIS and the status of the specimens margins
as resulted at final pathology.
Materials and methods
All consecutive patients conservatively operated from
January 2001 to December 2009 due to preoperative
stereotactic core biopsy positive for DCIS were included
in the study. Patients diagnosed with DCIS who under-
went primary mastectomy as well as those with palpable
lesions were not included; patients treated with comple-
tion mastectomy as secondary surgery were included in
the assessment of margin involvement after primary sur-
gery but were excluded from the evaluation of ipsilateral
breast tumor recurrence (IBTR).
Object of the study is a workflow outlined as follows: the
biopsy site is marked with a clip at the time of the diagnos-
tic procedure and the same clip is targeted with
technetium-99 m-macroaggregate albumin the afternoon
prior to surgery according to the ROLL technique (Gennari
et al. 2000) (Radioguided Occult Lesion Localization); if the
clip appears to be displaced, the target of the ROLL is the
centre of the pathologic area. Multiple seeds are used toFigure 1 Intraoperative specimen mammograms. Yellow arrows: adequ
radiological margin from a cluster of microcalcifications (a) or tumor boundbracket large lesions or areas of microcalcifications at the
radiologist’s discretion.
During surgery, an intra-operative digital mammogram
of the specimen is taken in order to verify the presence
of the clip and the lesion as outlined on preoperative
mammograms. Preoperative ROLL and intra-operative
radiograph are routinely performed by the same radiolo-
gist and the correct orientation of the specimen is as-
sured by the placement of stitches and radiopaque clips
on the sample during surgery according to a written
standard pattern, reported on a dedicated form. It pre-
supposes the placement of two stitches on the cephalad
margin (each one marked with a radiopaque surgical clip
on its very base), one stitch on the caudal margin
(marked with a single radiopaque surgical clip positioned
at the base) and a different suture (with no radiopaque
marker) on the margin close to the nipple; this margin is
indicated during the mammogram by a U-shaped metal
marker (Figure 1). If no skin is removed with the speci-
men, the superficial margin is inked. No compression is
used; radio-transparent props are used if necessary to
optimize the orientation of the specimen.
The distance from the boundary of the tumor (or from
the outermost microcalcification) to the edge of the spe-
cimen is assessed in all directions on the digital mam-
mogram and additional tissue is removed where it
measures less then 15 mm (Figure 1).ate (15 mm. or more) radiological margin. Red arrows: inadequate
ary (b).
Table 1 Non-negative margins in 272 consecutive
conservative surgical treatment
Number of involved margins Total
one two three
“Positive” margins 30 12 2 44
“Close” margins 8 1 - 9
Total 38 13 2 53
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techniques are employed on demand, according to the cri-
teria outlined by Clough et al. (2010).
Histopathological examination is conducted with tan-
gential method (shaved, “en face”).
Pathology reports were reviewed and specimens margins
classified as “negative” if the microscopic distance from
the tumor was at least 2 mm, as “close” if comprised be-
tween 1.9 and 1 mm and as “positive” if lesser than 1 mm.
With the purpose of statistical analysis, margin status was
classified as “negative” versus “non-negative” (grouping
“positive” and “close”).
Tumor grading was scored according to the Nottingham
combined histological grading system (Elston & Ellis 1991).
Immuno-histochemistry was used to assess ER- and PgR-
status and Ki67. Fluorescence in-situ hybridization (FISH)
was employed to determine HER2 amplification. ER- and
PgR-status were considered “positive” if at least 10% of
cells stained and otherwise “negative”. Ki-67 expression
was classified as “high” if at least 20% of cells stained or
“low”. HER2 amplification was defined according to guide-
lines issued by the American College of Pathologists (Les-
ter et al. 2009).
The specimens of patients who underwent re-excision
were analyzed with the same methods used for primary
surgery; residual tumor was reported as “present” or
“absent”.
Secondary surgery was indicated according to clinical
judgement, using criteria similar to those reported by
others (Morrow et al. 2012); indications were: age below
70, unfavorable biological features of tumor, extensive infil-
tration of a single margin or more than one margin infil-
trated. On the other hand, indications to post-operative
radiotherapy and adjuvant treatment (without re-operation
) were: age above 70, favorable biological features of tumor,
infiltration of one margin only.
The administration of radiotherapy was recorded and
Patients were regularly followed-up after surgery. Adju-
vant hormonal therapy is not routinely delivered for
non-infiltrating carcinomas at our institution and occa-
sional indications were issued upon individual-case
multidisciplinary discussion.
Main outcome of the study was the rate of margin in-
volvement at pathology. Secondary outcomes were re-
excision rate and IBTR rate.
The database was anonymized assigning to each pa-
tient a unique identifier and deleting sensitive data.
When anonymized administrative and clinical data are
used to inform health care planning activities, the study
is exempt from notification to the Ethics Committee and
no specific written consent is needed to use patient in-
formation stored in the hospital databases.
An IBTR was defined as the occurrence of DCIS or in-
vasive cancer in the treated breast. For each patient,time to failure was collected for all IBTRs, defined as
time from the definitive surgery to the first occurrence
of IBTR. Patients without IBTR were censored at the
date of last follow-up. The date and type of recurrence
(invasive vs. in situ), and the last date of follow-up were
recorded for each patient after initial treatment.
The cumulative incidence of local relapse was estimated
by Kaplan-Meier method (1958). The correlation between
margin involvement and other clinico-pathological vari-
ables was assessed using a multiple logistic regression
model in univariate and multivariate analyses.
All p-values were based on two-sided testing (p < 0.05)
and statistical analysis was performed by using SAS statis-
tical software (version 9.3, SAS Institute, Cary, NC). No
formal sample size was planned, no multiplicity p value
correction was implemented.Results
From January 2001 to December 2009, 339 patients
underwent conservative surgery because of preoperative
diagnosis of DCIS; 67 patients whose final pathology re-
port showed coexistent infiltrating carcinoma (either at
primary surgery or at re-operation) were excluded and
therefore 272 patients constitute the study population.
At final pathology, 219 specimens (80.51%) had negative
margins, 9 (3.31%) had close margins and 44 (16.18%) had
positive margins (Table 1). Among the 53 non-negative
margins, no further surgery was indicated in 25 (47.2%)
cases while re-operation was undertaken in 28 (52.8%)
cases (corresponding to 10.3% of the whole series),
performing re-excision in 13 cases and completion mastec-
tomy in 15; no residual tumor could be detected in the
specimens from secondary surgery in 9 cases (32.1%).
Median patients age was 58 (range:30–83). Nuclear
grading was scored G1 in 47 (17.9%) cases, G2 in 115
(43.9%) and G3 in 100 (38.2%); it was not assessed in 10
patients. Tumors proved ER-positive in 122 cases (74.4%)
and ER-negative in 42 (25.6%); PgR resulted positive in
101(61.6%) cases and negative in 63 (38.4%). Hormone re-
ceptors were not determined in 108 cases. Ki-67 expres-
sion was “high” in 20 cases (12.5%) and “low” in 140 cases
(87.5%); it was not assessed in 112 cases. HER2-status was
tested in 53 cases and resulted amplified in 16 cases
(30.2%) (Table 2).
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after primary surgery who underwent completion mastec-
tomy were excluded from further analysis of recurrence
rate; therefore, 257 cases were candidate to breast conser-
vative treatment: 207 (81.5%) received post-operative
radiotherapy while 47 (18.5%) did not (in 3 cases data were
not available).
After a median follow-up of 63 months (range: 7–126),
22 IBTRs were observed (8.56%), as DCIS in 10 cases
(45%) and as infiltrating carcinomas in 12 (55%); 17 recur-
rences took place in patients whose specimen margins had
resulted “negative” while in 5 cases the margins had
resulted “close” (1 case) or “positive” (4 cases).
Overall, 5-year relapse cumulative incidence was 9.2%
(95% CI: 5.9-14.3). Five-year relapse cumulative incidence
was 8.5% (95% CI: 5.2-13.8) for negative margins and
16.4% (95% CI: 5.5-43.2) for positive margins (Figure 2).Table 2 Biological features of 272 DCIS
n. (%) Non-negative Negative
Margins a Margins
(N = 53) (N = 219)
Age
24 ≤50 81 (29.7) 16 65
>50 191 (70.3) 37 154
ER status
Negative 42 (25.6) 6 36
Positive 122 (74.4) 30 92
Unknown 108
PgR status
Negative 63 (38.4) 13 50
Positive 101 (61.6) 22 79
Unknown 108
Ki-67 proliferative index
<20% 140 (87.5) 31 109
≥20% 20 (12.5) 5 15
Unknown 112
HER2 status
Amplified 16 (30.2) 9 7
Not amplified 37 (69.8) 8 29
Unknown 219
Grading
G1 47 (17.8) 2 45
G2 115 (43.9) 22 93




HER2: Human Epidermal growth factor Receptor 2.
a “Non-negative” margins include margins classified either as “positive” or as
“close” (see text).Discussion
Breast cancer treatment requires a multidisciplinary ap-
proach and it’s recommendable that an organized pathway
through the disciplines involved is granted to patients in
order to optimize clinical outcomes. The purpose in the
treatment of DCIS is to maximize local control with the
least-aggressive treatment (Kumar & Sacchini 2010). The
extent of disease within the breast and the presence of
multifocality, which in turn affect the ability to achieve
negative margins, heavily influence surgical planning (Dick
et al. 2011) but, unfortunately, precise preoperative assess-
ment of DCIS extension remains elusive because trad-
itional clinical evaluation proved unreliable (Holland et al.
1985) and recent diagnostic tools showed some limitations
as well. MRI can in facts detect DCIS (in particular high-
or intermediate-grade lesions) but it does not accurately
predict the size of the tumor and does not improve the
surgeon's ability to achieve clear margins following breast-
conservative surgery (Kropcho et al. 2012).
As far as intraoperative evaluation is concerned,
Chagpar et al. (2003) claimed that radiologic assessment
alone is insufficient for accurate evaluation of margin sta-
tus, because margins that appear negative on specimen
radiography may be histologically positive in up to 44% of
cases. Therefore, a technique for intraoperative margin as-
sessment that includes sliced specimen radiography and
gross pathological examination was reported; the addition
of gross pathological examination led to a 28%-rate of
intraoperative negative margins that actually resulted posi-
tive on final pathology; these results appear slightly worse
than the 19.5% rate of positive margins at final pathology
that we observed. Unfortunately, as reported by the
Chagpar et al., frozen section analysis is not felt to be indi-
cated in cases with microcalcifications because it may in-
duce artifacts and leave insufficient unfrozen tissue for
permanent sections, so in our opinion the radiological
margin that we adopted allowed to overcome some limita-
tions existing in intraoperative pathological examination.
In the present series, a consistent radiological margin
was used and eventually 219 cases (80.51%) out of 272
conservative treatments had negative margins at pathology
after primary surgery; among the 53 non-negative mar-
gins, the majority (71.7%) had only one margin involved,
either as “positive” or “close”. Re-operation was under-
taken in 28 cases (10.3%), requiring completion mastec-
tomy in 15 cases (5.5%); therefore, the treatment of 257
cases out of 272 (94.5%) was eventually confirmed as
conservative.
The re-operation rate that we recorded (10.3%) com-
pares favorably, for instance, with the 60.5% reported by
Rudloff in their observational study of 304 women with
DCIS treated with breast-conserving therapy (Rudloff
et al. 2010). In another population-based study (Morrow
et al. 2009), a 42.7% rate of additional surgery is reported,
Figure 2 Cumulative incidence of local relapse according to margin status.
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mastectomy (12%).
However, re-excision rates reported in the literature
are quite variable and the variation parallels different
definitions of “adequate” margin, often not supported by
consistent high-quality clinical data (Azu et al. 2010).
Considerable debate also concerns the definition of
“negative” margin and whether the width of a negative
margin (width of a margin negative for tumor cells) is asso-
ciated with a decreased risk of recurrence. Some evidence
in the literature supports the conclusion that wider nega-
tive margins confer the greatest protection (Kerlikowske
et al. 2003), but no study comparing women whose mar-
gins were above or below a specific threshold found any
benefit to being above vs. below the threshold (Virnig et al.
2010). Besides, a significant proportion of re-excisions
are reported to be done in patients with negative margins
(Azu et al. 2010).
Due to uncertainty about “adequate”margin, indication
to secondary surgery is to some extent subjective and
our work constitutes no exception, but it is worth no-
ticing that in the present series no residual tumor in the
specimens from secondary surgery could be detected in
only 9 cases (32.1%), meaning that the choice of no sur-
gical indication in non-negative margin cases would have
left in place residual cancer in 67.9% of cases. Within
the frame of a low margin-involvement rate, we consider
this figure an estimate of consistent predictive value of
the margins assessment we adopted (and a proxy of
sound indications to secondary surgery).
Within a low overall reoperation rate, in our series a
mastectomy was undertaken roughly half of the timesthat a secondary surgery was indicated, and therefore indi-
cations to BCT were eventually turned into a demolitive
operation in 5.5% of cases. This figure may be interpreted
as a fulfillment of patients’ cosmetic demands, but in the
present study no survey of patient satisfaction concerning
cosmetic outcome was carried on and this may be consid-
ered as a limit of the work.
After a median follow-up of 63 months we recorded a
8.56% relapse rate, which compares similarly with the
Silverstein’s series (1999), where an IBTR rate as low as
6% at 5 years was reported for patients with small lesions,
favorable histologies, and low/intermediate grade with
widely negative margins (>1 cm) treated by BCS alone.
Our results may be influenced by the low proportion of
high grade DCIS (38.2%), the presence of mostly ER-
positive (74.4%) lesions and the high proportion of patients
receiving post-operative radiotherapy (80.5%). In facts,
there are conflicting retrospective data demonstrating
higher local relapse rates even in these favorable patients
groups, with the omission of radiation therapy (Motwani
et al. 2011). As reported in the series by Rudloff (2010), in
the most favorable subgroup (margin width ≥10 mm, older
age, absent palpable mass, absent lobular neoplasia), the
10-year cumulative IBTR rate was 13% without RT. Unfor-
tunately, the small numbers in our series did not allow a
comparison between patients who underwent RT and
those who did not. Besides, long follow-up periods appear
to be necessary in order to be able to detect IBTRs. In the
randomized National Surgical Adjuvant Breast Project
(NSABP) B-17 trial and in the European Organization for
Research and Treatment of Cancer (EORTC) trial, the
rates of IBTR increased by nearly 40% after 5 years
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Rudloff (2010), 21% of recurrences took place after a me-
dian follow-up of 11 years and actuarial 10- and 15-year
IBTR rates for all patients were 22% and 29%, respectively.
In the series by Motwani (2011) the majority of local re-
lapses occurred after 5 years and this late development was
more apparent in the low/intermediate grading cohort
(75%) versus the high grade cohort (50%). Therefore IBTR
rates will likely increase in our series, as the follow-up
period extends.
In conclusion, in our experience an intra-operative
“adequate” margin of at least 15 mm as defined on
intraoperative mammogram of the specimen has allowed
to obtain a high rate of histologically negative margin at
primary surgery (80.51%); this finding was paralleled by a
10.3% reoperation rate, with a high (94.5%) likelihood of
eventually maintain indications to conservative surgery,
often permitted by recourse to oncoplastic techniques.
Hopefully, further studies will allow to understand
whether smaller radiological margins grant low margin
positivity on final pathology after primary surgery.
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